Oramed Pharmaceuticals Inc. trades by members of Congress

Purchases and sales of Oramed Pharmaceuticals Inc. shares that members of the House have disclosed since January 3, 2015, with the value range each one reported and a link to the original filing.

Purchases, last 12 months 0 trades None disclosed

Sales, last 12 months 0 trades None disclosed

Members trading, last 12 months 0 4 purchases and sales since January 3, 2015

Oramed Pharmaceuticals Inc. trades disclosed by members of Congress
				Report
Brad Knott House · R-NC 13	Sale (full)$15,001 - $50,000	Feb 25, 2025	Jan 10, 2025	Filing for ORMP on Jan 10, 2025
Andrew R. Garbarino House · R-NY 2	Sale (full)$1,001 - $15,000	Jan 14, 2022	Jan 14, 2022	Filing for ORMP on Jan 14, 2022
Andrew R. Garbarino House · R-NY 2	Sale (partial)$1,001 - $15,000	Nov 3, 2021	Oct 1, 2021	Filing for ORMP on Oct 1, 2021
Andrew R. Garbarino House · R-NY 2	Purchase$1,001 - $15,000	May 24, 2021	Apr 23, 2021	Filing for ORMP on Apr 23, 2021

Source: periodic transaction reports filed with the Clerk of the House of Representatives under the STOCK Act (Senate reports are not included yet). Members report trades by themselves, their spouses and dependent children. Amounts are the value ranges as filed, not exact figures, and a report can be filed up to 45 days after the trade, so the latest trades may not appear yet. Scanned paper reports are linked but not transcribed. By law (5 U.S.C. §13107) these reports may not be used for any commercial purpose other than by news and communications media for dissemination to the general public; we publish them free, as news.

← Back to Oramed Pharmaceuticals Inc. · Insider trading · Funds · All trades by members of Congress